OWC Pharmaceutical Research Corp. Share Price
Equities
OWCP
US67109N1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
2021 | OWC Pharmaceutical Research Corp. Announces Resignation of David Kugelman as the Sole Director | CI |
2021 | Discover Growth Enters into Agreement with OWC Pharmaceutical | CI |
Sales 2017 | - | Sales 2018 | - | Capitalization | 15.37M 1.21B |
---|---|---|---|---|---|
Net income 2017 | -4M -315M | Net income 2018 | -10M -787M | EV / Sales 2017 | - |
Net cash position 2017 | 971K 76.34M | Net cash position 2018 | 3.46M 272M | EV / Sales 2018 | - |
P/E ratio 2017 |
-14.5
x | P/E ratio 2018 |
-1.21
x | Employees | 9 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
1 day | -99.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 20/06/20 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 15/06/14 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/11/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 24/06/20 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 20/06/20 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
Date | Price | Change | Volume |
---|---|---|---|
17/05/24 | 0.000001 | -99.00% | 6,888 |
16/05/24 | 0.0001 | +9,900.00% | 4,000 |
Delayed Quote OTC Markets, May 17, 2024 at 02:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 497 | |
-18.82% | 18.18B | |
-43.89% | 2.84B | |
+23.49% | 1.94B | |
-3.70% | 1.64B | |
+31.41% | 1.33B | |
-16.85% | 953M | |
-23.12% | 891M | |
+3.17% | 865M | |
+24.76% | 543M |
- Stock Market
- Equities
- OWCP Stock